We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$73.4B
AUM Growth
+$1.61B
Cap. Flow
+$213M
Cap. Flow %
0.29%
Top 10 Hldgs %
34.33%
Holding
4,167
New
209
Increased
1,381
Reduced
1,653
Closed
198
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWQ icon
3476
iShares MSCI France ETF
EWQ
$328M
$5.14K ﹤0.01%
136
IMTX icon
3477
Immatics
IMTX
$1.23B
$5.08K ﹤0.01%
437
-74
-14% -$834
VRE
3478
DELISTED
Veris Residential
VRE
$5.05K ﹤0.01%
337
+6
+2% +$90
CSTL icon
3479
Castle Biosciences
CSTL
$742M
$5.05K ﹤0.01%
232
-234
-50% -$5.21K
LMND icon
3480
Lemonade
LMND
$3.64B
$5.03K ﹤0.01%
305
-387
-56% -$6.46K
MIRM icon
3481
Mirum Pharmaceuticals
MIRM
$6.56B
$5.03K ﹤0.01%
147
-9
-6% -$236
OLP
3482
One Liberty Properties
OLP
$542M
$5.03K ﹤0.01%
214
ALT icon
3483
Altimmune
ALT
$568M
$4.99K ﹤0.01%
750
-19,067
-96% -$141K
AAPL icon
3484
PUT
Apple
AAPL
$4.97T
$4.96K ﹤0.01%
40
+10
+33% +$1.86K
HNVR icon
3485
Hanover Bancorp
HNVR
$190M
$4.95K ﹤0.01%
300
KREF
3486
KKR Real Estate Finance Trust
KREF
$466M
$4.92K ﹤0.01%
544
-903
-62% -$8.63K
XSVM icon
3487
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$679M
$4.92K ﹤0.01%
94
-40
-30% -$2.17K
ZVRA icon
3488
Zevra Therapeutics
ZVRA
$578M
$4.9K ﹤0.01%
1,000
SABR icon
3489
Sabre
SABR
$716M
$4.88K ﹤0.01%
1,828
+1,088
+147% +$3.05K
JRI icon
3490
Nuveen Real Asset Income & Growth Fund
JRI
$350M
$4.87K ﹤0.01%
+400
New +$4.63K
WHWK
3491
Whitehawk Therapeutics
WHWK
$181M
$4.87K ﹤0.01%
3,333
TNGX icon
3492
Tango Therapeutics
TNGX
$4.21B
$4.87K ﹤0.01%
567
+103
+22% +$796
VMD icon
3493
Viemed Healthcare
VMD
$447M
$4.86K ﹤0.01%
742
-2,458
-77% -$18.5K
SBSI icon
3494
Southside Bancshares
SBSI
$963M
$4.86K ﹤0.01%
176
-2,588
-94% -$70.2K
MHF
3495
Western Asset Municipal High Income Fund
MHF
$151M
$4.83K ﹤0.01%
713
AUTL
3496
Autolus Therapeutics
AUTL
$389M
$4.81K ﹤0.01%
1,382
-2
-0.1% -$9
EQBK icon
3497
Equity Bancshares
EQBK
$1.04B
$4.79K ﹤0.01%
136
EWY icon
3498
iShares MSCI South Korea ETF
EWY
$20.1B
$4.76K ﹤0.01%
72
ABCL icon
3499
AbCellera Biologics
ABCL
$1.65B
$4.72K ﹤0.01%
1,596
-1,359
-46% -$5.14K
MOFG
3500
DELISTED
MidWestOne Financial Group
MOFG
$4.72K ﹤0.01%
210

Similar funds

US Bancorp's Q2 2024 Portfolio in Review

As of Q2 2024, US Bancorp held 4,167 positions worth $73.4B, up 2.2% from $71.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

US Bancorp's Q2 2024 filing shows 209 new, 1,381 increased, 1,653 reduced and 198 closed positions. Its largest new stake was Solventum: 547,442 shares worth $28.9M. The largest sale was Vanguard Total Stock Market ETF, an estimated $1.24B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q2 2024 buy was Solventum: 547,442 shares worth $28.9M.
  • US Bancorp added most to Schwab US Large- Cap ETF in Q2 2024, an estimated $882M increase.
  • US Bancorp's biggest Q2 2024 reduction was Vanguard Total Stock Market ETF, cutting an estimated $1.24B.
  • US Bancorp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $24M.
  • US Bancorp's ten largest holdings make up 34% of its $73.4B portfolio in Q2 2024.
  • US Bancorp opened 209 new positions and closed 198 in Q2 2024.
  • US Bancorp's portfolio value rose 2.2% quarter-over-quarter to $73.4B.

Based on US Bancorp's 13F filing for Q2 2024, filed 7 Aug 2024.